These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32932250)

  • 1. OVOL1/2: Drivers of Epithelial Differentiation in Development, Disease, and Reprogramming.
    Saxena K; Srikrishnan S; Celia-Terrassa T; Jolly MK
    Cells Tissues Organs; 2022; 211(2):183-192. PubMed ID: 32932250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
    Roca H; Hernandez J; Weidner S; McEachin RC; Fuller D; Sud S; Schumann T; Wilkinson JE; Zaslavsky A; Li H; Maher CA; Daignault-Newton S; Healy PN; Pienta KJ
    PLoS One; 2013; 8(10):e76773. PubMed ID: 24124593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma.
    Ito T; Tsuji G; Ohno F; Uchi H; Nakahara T; Hashimoto-Hachiya A; Yoshida Y; Yamamoto O; Oda Y; Furue M
    Am J Pathol; 2016 Apr; 186(4):1036-43. PubMed ID: 26873447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells.
    Lee B; Villarreal-Ponce A; Fallahi M; Ovadia J; Sun P; Yu QC; Ito S; Sinha S; Nie Q; Dai X
    Dev Cell; 2014 Apr; 29(1):47-58. PubMed ID: 24735878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the OVOL1-OVOL2 axis in normal and diseased human skin.
    Tsuji G; Ito T; Chiba T; Mitoma C; Nakahara T; Uchi H; Furue M
    J Dermatol Sci; 2018 Jun; 90(3):227-231. PubMed ID: 29454536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OVOL2: an epithelial lineage determiner with emerging roles in energy homeostasis.
    Jiang Y; Zhang Z
    Trends Cell Biol; 2023 Oct; 33(10):824-833. PubMed ID: 37336658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL2 induces mesenchymal-to-epithelial transition in fibroblasts and enhances cell-state reprogramming towards epithelial lineages.
    Watanabe K; Liu Y; Noguchi S; Murray M; Chang JC; Kishima M; Nishimura H; Hashimoto K; Minoda A; Suzuki H
    Sci Rep; 2019 Apr; 9(1):6490. PubMed ID: 31019211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 9. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
    Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
    Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of trophoblast implantation to the maternal endometrium.
    Bai R; Kusama K; Nakamura K; Sakurai T; Kimura K; Ideta A; Aoyagi Y; Imakawa K
    FASEB J; 2018 Jun; 32(6):3371-3384. PubMed ID: 29394105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates.
    Kagawa H; Shimamoto R; Kim SI; Oceguera-Yanez F; Yamamoto T; Schroeder T; Woltjen K
    Stem Cell Reports; 2019 Feb; 12(2):319-332. PubMed ID: 30639212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovol proteins: guardians against EMT during epithelial differentiation.
    Li S; Yang J
    Dev Cell; 2014 Apr; 29(1):1-2. PubMed ID: 24735874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OVO-like 1 regulates progenitor cell fate in human trophoblast development.
    Renaud SJ; Chakraborty D; Mason CW; Rumi MA; Vivian JL; Soares MJ
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6175-84. PubMed ID: 26504231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OVOL guides the epithelial-hybrid-mesenchymal transition.
    Jia D; Jolly MK; Boareto M; Parsana P; Mooney SM; Pienta KJ; Levine H; Ben-Jacob E
    Oncotarget; 2015 Jun; 6(17):15436-48. PubMed ID: 25944618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [OvoL factors: a family of key regulators of epithelium mesenchyme plasticity and stem cells].
    Mancheno-Ferris A; Polesello C; Payre F
    Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():61-66. PubMed ID: 33052097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.
    Murata M; Ito T; Tanaka Y; Yamamura K; Furue K; Furue M
    J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32106476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
    Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
    Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma.
    Fu H; Qi L; Chen L; He Y; Zhang N; Guo H
    Onco Targets Ther; 2016; 9():5963-5973. PubMed ID: 27729805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermis.
    Teng A; Nair M; Wells J; Segre JA; Dai X
    Biochim Biophys Acta; 2007 Jan; 1772(1):89-95. PubMed ID: 17049212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progression.
    Roca H; Pande M; Huo JS; Hernandez J; Cavalcoli JD; Pienta KJ; McEachin RC
    BMC Syst Biol; 2014 Mar; 8():29. PubMed ID: 24612742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.